Switch to:

No ownership data available.

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Broom Colin MDVP & Chief Scientific Officer2012-12-24Sell17,50037,667$22.53394.3121.7537,667 (Direct)
Broom Colin MDVP & Chief Scientific Officer2012-12-24Sell17,50020,167$22.53394.3121.7520,167 (Direct)
BROOKE PAUL ADirector2012-12-13Sell60,000104,500$23.871432.2109.3104,500 (Direct)
Broom Colin MDVP & Chief Scientific Officer2012-12-10Sell74,99937,667$24.071805.2107.5637,667 (Direct)
CLAYPOOL WILLIAM D MDDirector2012-12-03Sell10,00044,500$24.8248101.4544,500 (Direct)
DOUGHERTY MICHAEL RDirector2012-12-03Buy2,5007,000$25.0762.799.287,000 (Direct)
Wolf John Peter IIIVP, General Counsel2012-12-03Sell18,0000$24.85447.3101.05Link
GLASER ROBERTDirector2012-11-30Sell30,00041,360$24.78743.4101.6141,360 (Direct)
CLAYPOOL WILLIAM D MDDirector2012-11-28Sell17,50054,500$24.22423.9106.2854,500 (Direct)
CLAYPOOL WILLIAM D MDDirector2012-11-13Sell22,50054,500$24.93560.9100.454,500 (Direct)
MILANO VINCENTPresident and CEO
(Click for the stocks that their CEOs have bought)
2012-11-08Sell83,41894,416$24.542047.1103.5994,416 (Direct)
CLAYPOOL WILLIAM D MDDirector2012-11-02Sell10,00054,500$25.37253.796.9354,500 (Direct)
CLAYPOOL WILLIAM D MDDirector2012-06-11Sell10,00064,500$20.04200.4149.364,500 (Direct)
Pietrusko RobertVP, Regulatory & Quality2012-03-23Sell20,0004,122$3060066.534,122 (Direct)
Fletcher Robert C.V.P., Business Development2012-03-09Sell32,000229$29.65948.868.5229 (Direct)
Morris Richard StevenChief Accounting Officer2012-03-09Sell1,3001,244$29.7138.668.161,244 (Direct)
Morris Richard StevenChief Accounting Officer2012-03-05Sell5,3001,244$33.0117551.351,244 (Direct)
DOYLE THOMAS FVP Strategic Initiatives2012-03-05Sell210,00052,444$32.486820.853.8252,444 (Direct)
Rowland Charles A JrVP, CFO2012-03-01Sell82,75017,125$32.122657.955.5417,125 (Direct)
SOLAND DANIEL BVP, COO2012-03-01Sell30,00042,881$32.99989.751.4442,881 (Direct)
Broom Colin MDVP & Chief Scientific Officer2011-12-14Sell50,00019,439$25.34126797.1619,439 (Direct)
14159 capital (GP), LLC10% Owner2011-12-14Buy7,828303,264$27.29213.683.07
303,264 (Through Partnership)
Baker Brothers Life Sciences C10% Owner2011-12-14Buy291,7069,840,469$27.297960.783.07
9,840,469 (Through Partnership)
Baker Biotech Capital (GP), LL10% Owner2011-12-14Buy50,5661,966,090$27.291379.983.07
1,966,090 (Through Partnership)
Broom Colin MDVP & Chief Scientific Officer2011-12-13Sell40,00019,439$23.5940112.619,439 (Direct)
DOYLE THOMAS FVP Strategic Initiatives2011-12-01Sell10,00052,444$23.82238.2109.7452,444 (Direct)
Pietrusko RobertVP, Regulatory & Quality2011-11-30Sell20,0003,910$24480108.173,910 (Direct)
GLASER ROBERTDirector2011-11-28Sell5,00036,860$23115117.2236,860 (Direct)
Pietrusko RobertVP, Regulatory & Quality2011-11-28Sell19,0003,910$23437117.223,910 (Direct)
Pietrusko RobertVP, Regulatory & Quality2011-11-23Sell1,0002,910$2323117.222,910 (Direct)
MILANO VINCENTPresident and CEO2011-11-21Sell76,68776,208$22.531727.8121.7576,208 (Direct)
Morris Richard StevenChief Accounting Officer2011-11-16Sell2,0001,165$22.5945.2121.161,165 (Direct)
Pietrusko RobertVP, Regulatory & Quality2011-11-14Sell20,0003,910$22440127.093,910 (Direct)
Broom Colin MDVP & Chief Scientific Officer2011-11-07Sell20,00019,439$21420137.919,439 (Direct)
Wolf John Peter IIIVP, General Counsel2011-11-07Sell12,2500$21.08258.2137Link
Broom Colin MDVP & Chief Scientific Officer2011-11-01Sell44,61619,439$20.22902.1147.0819,439 (Direct)
Baker Biotech Capital (GP), LL10% Owner2011-10-05Buy18,7891,915,524$18.09339.9176.17
1,915,524 (Through Partnership)
Baker Brothers Life Sciences C10% Owner2011-10-05Buy191,3479,548,763$18.013446.2177.4
9,548,763 (Through Partnership)
14159 capital (GP), LLC10% Owner2011-10-05Buy7,922295,436$18.01142.7177.4
295,436 (Through Partnership)
Baker Brothers Life Sciences C10% Owner2011-10-03Buy898,0969,357,416$17.8416022180.04
9,357,416 (Through Partnership)
14159 capital (GP), LLC10% Owner2011-09-30Buy14,519287,514$18.03261.8177.09
287,514 (Through Partnership)
Baker Biotech Capital (GP), LL10% Owner2011-09-30Buy53,2051,896,735$18.04959.8176.94
1,896,735 (Through Partnership)
Baker Biotech Capital (GP), LL10% Owner2011-09-26Buy72,8491,843,530$17.841299.6180.04
1,843,530 (Through Partnership)
Baker Brothers Life Sciences C10% Owner2011-09-26Buy447,5618,459,320$17.837980180.2
8,459,320 (Through Partnership)
14159 capital (GP), LLC10% Owner2011-09-26Buy17,729272,995$17.83316.1180.2
272,995 (Through Partnership)
Pietrusko RobertVP, Regulatory & Quality2011-08-31Sell20,0003,910$20400149.83,910 (Direct)
Baker Biotech Capital (GP), LL10% Owner2011-08-23Buy5,4681,770,681$16.9792.8194.4
1,770,681 (Through Partnership)
Baker Brothers Life Sciences C10% Owner2011-08-23Buy32,7048,011,759$16.97555194.4
8,011,759 (Through Partnership)
14159 capital (GP), LLC10% Owner2011-08-23Buy503255,266$16.978.5194.4
255,266 (Through Partnership)
14159 capital (GP), LLC10% Owner2011-08-10Buy5,934254,763$16.5898.4201.33
254,763 (Through Partnership)
Baker Brothers Life Sciences C10% Owner2011-08-10Buy244,0497,979,055$16.584046.3201.33
7,979,055 (Through Partnership)
Rowland Charles A JrVP, CFO2011-03-14Sell35,0000$18.57650169.04Link
CLAYPOOL WILLIAM D MDDirector2011-03-03Sell38,6410$18.27706173.45Link
GLASER ROBERTDirector2010-12-14Sell5,00036,860$16.7583.8198.27Link
Morris Richard StevenChief Accounting Officer2010-12-09Sell14,500569$16.56240.1201.69Link
CLAYPOOL WILLIAM D MDDirector2010-11-09Sell6,35960,000$17.03108.3193.36Link
Broom Colin MDVP & Chief Scientific Officer2010-09-13Sell30,00015,113$13.26397.8276.77Link
GLASER ROBERTDirector2010-05-27Sell5,00041,860$12.562.5299.68Link
14159 capital (GP), LLC10% Owner2010-05-10Sell96,120248,829$12.651215.9294.94Link
Baker Biotech Capital (GP), LL10% Owner2010-05-10Sell847,7862,288,013$12.6510724.5294.94Link
SOLAND DANIEL BVP, COO2010-05-07Buy20,00093,638$12.22244.4308.84Link
Baker Brothers Life Sciences C10% Owner2010-04-30Buy1,946,2779,080,664$12.8725048.6288.19Link
14159 capital (GP), LLC10% Owner2010-04-30Buy53,723241,295$12.87691.4288.19Link
14159 capital (GP), LLC10% Owner2010-04-30Buy157,377344,949$12.912031.7286.99Link
Baker Biotech Capital (GP), LL10% Owner2010-04-30Buy1,242,0043,135,799$12.9416071.5286.09Link
Baker Brothers Life Sciences C10% Owner2010-04-28Buy600,6197,735,006$12.727639.9292.77Link
14159 capital (GP), LLC10% Owner2009-05-21Buy1,063187,572$6.086.5721.71
Baker Brothers Life Sciences C10% Owner2009-05-21Buy38,1207,134,387$6.08231.8721.71
Baker / Tisch Capital (GP), LL10% Owner2009-05-21Buy8684,425$6.080.5721.71
Baker Bros. Capital (GP), LLC10% Owner2009-05-21Buy24105,798$6.080.1721.71
Baker / Tisch Capital (GP), LL10% Owner2009-05-19Buy38284,339$5.982.3735.45
Baker Bros. Capital (GP), LLC10% Owner2009-05-19Buy108105,774$5.980.6735.45
Baker Brothers Life Sciences C10% Owner2009-05-19Buy169,1127,096,267$5.981011.3735.45
14159 capital (GP), LLC10% Owner2009-05-19Buy4,711186,509$5.9828.2735.45
Baker / Tisch Capital (GP), LL10% Owner2009-05-13Buy99683,957$5.465.4815.02
14159 capital (GP), LLC10% Owner2009-05-13Buy12,279181,798$5.4667815.02
Baker Brothers Life Sciences C10% Owner2009-05-13Buy440,6236,927,155$5.462405.8815.02
Baker Bros. Capital (GP), LLC10% Owner2009-05-13Buy279105,666$5.461.5815.02
Baker Bros. Capital (GP), LLC10% Owner2009-05-11Buy282105,387$5.811.6759.9
Baker / Tisch Capital (GP), LL10% Owner2009-05-11Buy1,01182,961$5.815.9759.9
Baker Brothers Life Sciences C10% Owner2009-05-11Buy446,8576,486,532$5.812596.2759.9
14159 capital (GP), LLC10% Owner2009-05-11Buy12,452169,519$5.8172.3759.9
SOLAND DANIEL BVP, COO2009-03-12Buy30,00070,000$4.05121.51133.58
CLAYPOOL WILLIAM D MDDirector2009-02-27Buy20,00060,000$3.9779.41158.44
DOYLE THOMAS FVP Strategic Initiatives2009-02-27Buy5,00050,807$3.9419.71168.02
Rowland Charles A JrVP, CFO2009-02-26Buy16,00024,000$4.7876.5945.19
DE ROSEN MICHELDirector2008-11-10Sell300,677137,100$12.153653.2311.19
Rowland Charles A JrVP, CFO2008-11-03Buy8,0008,000$12.77102.2291.23
DOUGHERTY MICHAEL RDirector2008-11-03Sell45,0000$12.76574.2291.54
Broom Colin MDVP & Chief Scientific Officer2008-09-12Sell25,35312,103$14.25361.3250.6
Morris Richard StevenChief Accounting Officer2008-09-11Sell2,200392$14.331.5249.37
Baker Brothers Life Sciences C10% Owner2008-03-17Buy59,3775,011,883$8.64513478.24
14159 capital (GP), LLC10% Owner2008-03-17Buy1,884129,574$8.6416.3478.24
Baker Biotech Capital (GP), LL10% Owner2008-03-17Buy22,0452,204,248$8.64190.5478.24
Baker Bros. Capital (GP), LLC10% Owner2008-03-17Buy158144,127$8.641.4478.24
Baker / Tisch Capital (GP), LL10% Owner2008-03-14Buy25474,977$8.692.2474.91
Baker Bros. Capital (GP), LLC10% Owner2008-01-09Buy473143,969$8.834.2465.8
Baker Biotech Capital (GP), LL10% Owner2008-01-09Buy68,5442,182,203$8.83605.2465.8
Baker / Tisch Capital (GP), LL10% Owner2008-01-09Buy3,62474,723$8.8332465.8
Baker Brothers Life Sciences C10% Owner2008-01-09Buy173,5254,952,506$8.831532.2465.8
14159 capital (GP), LLC10% Owner2008-01-09Buy5,512127,690$8.8348.7465.8
14159 capital (GP), LLC10% Owner2007-11-09Buy26,133122,178$7.43194.2572.41
Baker Bros. Capital (GP), LLC10% Owner2007-11-09Buy2,213143,496$7.4316.4572.41
Baker Biotech Capital (GP), LL10% Owner2007-11-09Buy326,8082,113,659$7.432428.2572.41
Baker / Tisch Capital (GP), LL10% Owner2007-11-09Buy2,91271,099$7.4321.6572.41
Baker Brothers Life Sciences C10% Owner2007-11-09Buy826,9344,778,981$7.436144.1572.41
SOLAND DANIEL BVP, Chief Commercial Officer2007-11-07Buy10,00040,000$7.2672.6588.15
SOLAND DANIEL BVP, Chief Commercial Officer2007-11-01Buy15,00030,000$8.31124.7501.2
MILANO VINCENTVP, COO & CFO2007-08-16Buy4,00060,942$8.1632.6512.25
DE ROSEN MICHELCEO2007-08-16Buy12,120361,400$8.1799511.51
SOLAND DANIEL BVP, Chief Commercial Officer2007-08-16Buy15,00015,000$8120524.5
CLAYPOOL WILLIAM D MDDirector2007-08-15Buy10,00040,000$8.3283.2500.48
GLASER ROBERTDirector2007-02-07Sell10,00038,860$18.02180.2177.25
GLASER ROBERTDirector2007-01-30Sell2,50038,860$1742.5193.88
GLASER ROBERTDirector2007-01-25Sell2,50038,860$1640212.25
DOYLE THOMAS FVP, General Counsel2006-12-06Sell7,00042,682$15.02105.1232.62
Leone John RDirector2006-09-08Buy2,0002,000$12.2524.5307.84Link
DE ROSEN MICHELCEO2006-05-09Buy10,100349,280$9.8499.4407.72Link
CLAYPOOL WILLIAM D MDDirector2006-05-08Buy10,00030,000$9.6496.4418.26Link
Baker / Tisch Capital (GP), LL10% Owner2006-02-28Sell23,846223,686$20.9498.4139.04Link
Baker Biotech Capital (GP), LL10% Owner2006-02-28Sell246,8412,150,377$20.95159139.04Link
Baker Biotech Capital II (Z) (10% Owner2006-02-28Sell31,558103,540$20.9659.6139.04Link
Baker Bros. Capital (GP), LLC10% Owner2006-02-28Sell48,745233,034$20.91018.8139.04Link
Baker Biotech Capital III (Z) 10% Owner2006-02-28Sell37,885122,122$20.9791.8139.04Link
14159 capital (GP), LLC10% Owner2006-02-28Sell43,07825,983$20.9900.3139.04Link
Baker Biotech Capital III (GP)10% Owner2006-02-28Sell195,7731,648,599$20.94091.7139.04Link
Baker Biotech Capital II (GP),10% Owner2006-02-28Sell223,4121,957,127$20.94669.3139.04Link
DE ROSEN MICHELCEO2005-12-14Buy10,530339,180$19.88209.3151.31Link
DOYLE THOMAS FVP, General Counsel2005-12-13Sell99,99914,281$19.821982152.07Link
MILANO VINCENTVP, CFO2005-12-13Sell59,99935,698$19.821189.2152.07Link
GLASER ROBERTDirector2005-12-13Sell30,00038,860$19.76592.8152.83Link
Tarnoff Joshua MVP, Commerical Operations2005-06-13Buy1,5001,500$6.69.9656.97Link
CLAYPOOL WILLIAM D MDDirector2005-06-10Buy10,00020,000$5.7457.4770.38Link
GLASER ROBERTDirector2005-06-06Buy12,50038,860$5.4868.5811.68Link
CLAYPOOL WILLIAM D MDDirector2005-05-26Buy10,00010,000$4.1411118.54Link
DOYLE THOMAS FVP, General Counsel2005-05-26Buy5,00014,281$3.8619.31194.3Link
GLASER ROBERTDirector2005-05-19Buy7,50026,360$3.7628.21228.72Link
DE ROSEN MICHELCEO2005-05-12Buy28,500328,650$3.511001323.36Link
BROOKE PAUL ADirector2005-05-11Buy126,500160,000$3.12394.71501.28Link
Baker Biotech Capital III (Z) 10% Owner2005-05-10Buy529980$1.8812557.45Link
Baker Biotech Capital II (Z) (10% Owner2005-05-10Buy415799$1.880.82557.45Link
Baker Biotech Capital III (GP)10% Owner2005-05-10Buy2,7555,103$1.885.22557.45Link
Baker Biotech Capital II (GP),10% Owner2005-05-10Buy2,9425,735$1.885.52557.45Link
Baker Biotech Capital (GP), LL10% Owner2005-05-10Buy3,2176,253$1.8862557.45Link
Baker Bros. Capital (GP), LLC10% Owner2005-05-10Buy6411,246$1.891.22543.39Link
14159 capital (GP), LLC10% Owner2005-05-10Buy228421$1.880.42557.45Link
Baker / Tisch Capital (GP), LL10% Owner2005-05-10Buy304605$1.890.62543.39Link
BROOKE PAUL ADirector2005-05-06Buy33,50033,500$2.4782.71922.67Link
Baker Biotech Capital III (Z) 10% Owner2005-01-31Buy451451$3.021.41554.3Link
14159 Capital (GP, LLC10% Owner2005-01-31Buy193193$3.020.61554.3Link
BAKER BROS CAPITAL GP LLC10% Owner2005-01-31Buy605605$3.021.81554.3Link
Baker Biotech Capital III (GP)10% Owner2005-01-31Buy2,3482,348$3.027.11554.3Link
BAKER TISCH CAPITAL GP LLC10% Owner2005-01-31Buy301301$3.020.91554.3Link
BAKER BIOTECH CAPITAL GP LLC10% Owner2005-01-31Buy3,0363,036$3.029.21554.3Link
Baker Biotech Capital II (Z) (10% Owner2005-01-31Buy384384$3.021.21554.3Link
BAKER BIOTECH CAPITAL II GP LL10% Owner2005-01-31Buy193193$3.020.61554.3Link
AVENTIS PHARMACEUTICALS INC2004-01-14Sell22,1002,616,000$3.5177.61323.36Link
AVENTIS PHARMACEUTICALS INC10% Owner2004-01-13Sell126,9002,638,100$3.39430.21373.75Link
AVENTIS PHARMACEUTICALS INC10% Owner2004-01-09Sell59,0002,765,000$3.18187.61471.07Link
AVENTIS PHARMACEUTICALS INC10% Owner2003-11-25Sell15,0122,824,000$3.1547.31486.03Link
AVENTIS PHARMACEUTICALS INC10% Owner2003-11-04Sell160,9882,839,012$3.19513.61466.14Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column) and "Shares Owned Following This (Direct & Indirect)" transactions (sixth column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK